#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS

The relationship of MicroRNA and osteoporosis when chronic heart failure is involved

Czech version

Authors: Martin Kužma;  Andrea Gažová;  Ján Kyselovič;  Juraj Payer
Authors‘ workplace: V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava
Published in: AtheroRev 2018; 3(2): 116-119
Category: Reviews

Overview

This article is aimed to review the current micro-RNA (miRNA) discoveries in clinical study in order to better characterize pathoetiology of comorbidity of HF and osteoporosis and possibly even finding miRNA targets, which would increase the level and accu­racy of prediction of the progress and/or treatment of both diseases.

Key words:

fractures heart, failure mikro-RNA, osteoporosis

Sources
  1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 2012; 125(1): e2-e220. Dostupné z DOI: <http://dx.doi.org/10.1161/CIR.0b013e31823ac046>. Erratum in Circulation 2012; 125(22): e1002.
  2. Tanko LB, Christiansen C, Cox DA et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005; 20(11): 1912–1920. Dostupné z DOI: <http://dx.doi.org/10.1359/JBMR.050711>.
  3. van Diepen S, Majumdar SR, Bakal JA et al. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation 2008; 118(19): 1946–1952. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.108.784009>.
  4. Frost RJ, Sonne C, Wehr U et al. Effects of calcium supplementation on bone loss and fractures in congestive heart failure. Eur J Endocrinol 2007; 156(3): 309–314. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-06–0614>.
  5. Sennerby U, Melhus H, Gedeborg R et al. Cardiovascular diseases and risk of hip fracture. Jama 2009; 302(15): 1666–1673. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2009.1463>.
  6. Carbone L, Buzkova P, Fink HA et al. Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 2010; 31(1): 77–84. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehp483>.
  7. Gerber Y, Melton LJ, Weston SA et al. Osteoporotic fractures and heart failure in the community. Am J Med 2011; 124(5): 418–425. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2010.11.029>.
  8. Lyons KJ, Majumdar SR, Ezekowitz JA. The unrecognized burden of osteoporosis-related vertebral fractures in patients with heart failure. Circ Heart Fail 2011; 4(4): 419–424. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCHEARTFAILURE.111.961185>.
  9. Majumdar SR, Ezekowitz JA, Lix LM et al. Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects. J Clin Endocrinol Metab 2012; 97(4): 1179–1186. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011–3055>.
  10. Mazziotti G, Baracca M, Doga M et al. Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure. Eur J Endocrinol 2012; 167(6): 865–872. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-12–0566>.
  11. Pfister R, Michels G, Sharp SJ et al. Low bone mineral density predicts incident heart failure in men and women: the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk prospective study. JACC Heart Fail 2014; 2(4): 380–389. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jchf.2014.03.010>.
  12. Bekfani T, Pellicori P, Morris DA et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. Int J Cardiol 2016; 222: 41–46. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijcard.2016.07.135>.
  13. McFarlane SI, Muniyappa R, Shin JJ et al. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine. 2004; 23(1): 1–10. Dostupné z DOI: <http://dx.doi.org/10.1385/ENDO:23:1:01>.
  14. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75(5): 843–854.
  15. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136(2) :215–233. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cell.2009.01.002>.
  16. Lee EJ, Baek M, Gusev Y et al. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 2008; 14(1): 35–42. Dostupné z DOI: <http://dx.doi.org/10.1261/rna.804508>.
  17. Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 2013; 15(6): 546–554. Dostupné z DOI: <http://dx.doi.org/10.1038/ncb2769>.
  18. Meiri E, Mueller WC, Rosenwald S et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist 2012; 17(6): 801–812. Dostupné z DOI: <http://dx.doi.org/10.1634/theoncologist.2011–0466>.
  19. Jing D, Hao J, Shen Y et al. The role of microRNAs in bone remodeling. Int J Oral Sci 2015; 7(3): 131–143. Dostupné z DOI: <http://dx.doi.org/10.1038/ijos.2015.22>.
  20. Nugent M. MicroRNAs and Fracture Healing. Calcif Tissue Int 2017; 101(4): 355–361. Dostupné z DOI: <http://dx.doi.org/10.1007/s00223–017–0296-x>.
  21. Liu T, Qin AP, Liao B et al. A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3). Bone 2014; 67: 156–165. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bone.2014.07.004>.
  22. Sugatani T, Hildreth BE, Toribio RE et al. Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity. J Cell Biochem 2014; 115(6): 1043–1047. Dostupné z DOI: <http://dx.doi.org/10.1002/jcb.24759>.
  23. Kumar S, Vijayan M, Bhatti JS et al. MicroRNAs as Peripheral Biomarkers in Aging and Age-Related Diseases. Prog Mol Biol Transl Sci 2017; 146: 47–94. Dostupné z DOI: <http://dx.doi.org/10.1016/bs.pmbts.2016.12.013>.
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adults
Cardiovascular safety of tocilizumab therapy: results of the ENTRACTE Clinical Trial
Cardiovascular risk in patients with rheumatoid arthritis
The effect of treatment of rheumatic diseases on cardiovascular risk
What a rheumatologist should know about statins and their side effects
The impact of rheumatic diseases on cardiovascular risk and lipidogram
Detection of aortic calcifications within the assessment of lateral densitometric scans
Familial chylomicronemia: pathogenesis, clinical manifestations and case study
Nutritional intervention in a female patient with familial chylomicronemia: a case report
Article was published in

Athero Review

Issue 2
2018 Issue 2
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#